127 related articles for article (PubMed ID: 3193400)
21. Properties of dopamine agonist and antagonist binding sites in mammalian retina.
Makman MH; Dvorkin B; Horowitz SG; Thal LJ
Brain Res; 1980 Aug; 194(2):403-18. PubMed ID: 6770965
[TBL] [Abstract][Full Text] [Related]
22. Characteristics of [3H]sultopride binding to rat brain.
Mizuchi A; Kitagawa N; Saruta S; Miyachi Y
Eur J Pharmacol; 1982 Oct; 84(1-2):51-9. PubMed ID: 6128237
[TBL] [Abstract][Full Text] [Related]
23. Pharmacology of binding of 3H-SCH-23390 to D-1 dopaminergic receptor sites in rat striatal tissue.
Faedda G; Kula NS; Baldessarini RJ
Biochem Pharmacol; 1989 Feb; 38(3):473-80. PubMed ID: 2563653
[TBL] [Abstract][Full Text] [Related]
24. Absence of [3H]SCH 23390 binding sites in the rat adrenal gland.
Zdilar D; Lacković Z
J Pharm Pharmacol; 1989 Sep; 41(9):646-8. PubMed ID: 2573713
[TBL] [Abstract][Full Text] [Related]
25. Competitive inhibition of [3H]spiperone binding to D-2 dopamine receptors in striatal homogenates by organic calcium channel antagonists and polyvalent cations.
De Vries DJ; Beart PM
Eur J Pharmacol; 1984 Oct; 106(1):133-9. PubMed ID: 6241565
[TBL] [Abstract][Full Text] [Related]
26. Properties of rat striatal D-2 dopamine receptors solubilized with the zwitterionic detergent CHAPS.
Kilpatrick GJ; Jenner P; Marsden CD
J Pharm Pharmacol; 1985 May; 37(5):320-8. PubMed ID: 2862240
[TBL] [Abstract][Full Text] [Related]
27. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
Neve KA; Altar CA; Wong CA; Marshall JF
Brain Res; 1984 Jun; 302(1):9-18. PubMed ID: 6428705
[TBL] [Abstract][Full Text] [Related]
28. Chronic proglumide increases [3H]spiperone binding in the rat brain.
Bean AJ; Baldy WJ; Martin GE
Eur J Pharmacol; 1985 Oct; 117(1):97-101. PubMed ID: 4085545
[TBL] [Abstract][Full Text] [Related]
29. Dopamine D2 receptor binding in adrenal medulla: characterization using [3H]spiperone.
Quik M; Bergeron L; Mount H; Philie J
Biochem Pharmacol; 1987 Nov; 36(21):3707-13. PubMed ID: 2960326
[TBL] [Abstract][Full Text] [Related]
30. Quantification of in vivo spiperone binding in the rat striatum after lesions produced by kainate or decortication.
Van der Werf JF; Van het Schip F; Sebens JB; Korf J
Eur J Pharmacol; 1984 Jul; 102(3-4):387-99. PubMed ID: 6436037
[TBL] [Abstract][Full Text] [Related]
31. Hyperprolactinaemia does not alter specific striatal 3H-spiperone binding in the rat.
Simpson MD; Jenner P; Marsden CD
Biochem Pharmacol; 1986 Oct; 35(19):3203-8. PubMed ID: 3768017
[TBL] [Abstract][Full Text] [Related]
32. Comparison of [3H]YM-09151-2 with [3H]spiperone and [3H]raclopride for dopamine d-2 receptor binding to rat striatum.
Terai M; Hidaka K; Nakamura Y
Eur J Pharmacol; 1989 Dec; 173(2-3):177-82. PubMed ID: 2576228
[TBL] [Abstract][Full Text] [Related]
33. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
Bennett JP; Wooten GF
Ann Neurol; 1986 Apr; 19(4):378-83. PubMed ID: 3707090
[TBL] [Abstract][Full Text] [Related]
34. Binding characteristics of the dopamine agonist/antagonist [3H]terguride (transdihydrolisuride) in the rat striatum.
Valchár M; Vrsecká M; Krejcí I; Dlabac A
Eur J Pharmacol; 1987 Apr; 136(1):97-101. PubMed ID: 3297739
[TBL] [Abstract][Full Text] [Related]
35. Development of specificity and stereoselectivity of rat brain dopamine receptors.
Miller JC; Friedhoff AJ
Int J Dev Neurosci; 1986; 4(1):21-6. PubMed ID: 2458672
[TBL] [Abstract][Full Text] [Related]
36. Analysis of [3H]spiperone binding sites in the rat striatum and frontoparietal cortex by means of quantitative receptor autoradiography after inactivation of dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by sulpiride in the striatum.
Fuxe K; Meller E; Goldstein M; Benfenati F; Agnati LF
Neurosci Lett; 1986 Feb; 64(2):163-8. PubMed ID: 3960398
[TBL] [Abstract][Full Text] [Related]
37. Specific [3H]piflutixol binding to CHAPS-solubilised rat striatal preparations involves dopamine D-2 but not D-1 binding sites.
Kilpatrick GJ; Jenner P; Marsden CD
J Neurochem; 1986 Feb; 46(2):413-21. PubMed ID: 3941314
[TBL] [Abstract][Full Text] [Related]
38. The binding of [3H]N-(chloroethyl)-norapomorphine to rat striatal membranes.
Kilpatrick GJ; Jenner P; Marsden CD
Eur J Pharmacol; 1984 Dec; 107(1):71-8. PubMed ID: 6084599
[TBL] [Abstract][Full Text] [Related]
39. Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors.
Cunha RA; Johansson B; Constantino MD; Sebastião AM; Fredholm BB
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):261-71. PubMed ID: 8692280
[TBL] [Abstract][Full Text] [Related]
40. Striatal D1- and D2-dopamine receptor sites are separately detectable in vivo.
Leslie CA; Bennett JP
Brain Res; 1987 Jul; 415(1):90-7. PubMed ID: 2957025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
